Pacific Biosciences Of California (PACB) Work In Process (2011 - 2026)

Pacific Biosciences Of California has reported Work In Process for 16 years, with the latest figure at $20.6 million in Q2 2026.

• On a quarterly basis, Work In Process fell 23.52% year-over-year to $20.6 million in Q2 2026; TTM through Jun 2026 was $20.6 million, a 23.52% decrease from a year earlier, with the FY2025 full-year figure at $16.4 million, down 25.83% from the prior year.
• Work In Process was $20.6 million for Q2 2026 at Pacific Biosciences Of California, down from $27.3 million in the prior quarter.
• The five-year high for Work In Process was $27.9 million in Q3 2023, with the low at $9.2 million in Q1 2022.
• Average Work In Process over 5 years is $21.1 million, with a median of $21.9 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Work In Process soared 135.87% in 2023, then sank 34.4% in 2024.
• Over 5 years, Work In Process stood at $14.1 million in 2022, then soared by 96.65% to $27.7 million in 2023, then fell by 19.82% to $22.2 million in 2024, then slipped by 25.83% to $16.4 million in 2025, then climbed by 25.13% to $20.6 million in 2026.
• The last three Work In Process figures came in at $20.6 million (Q2 2026), $27.3 million (Q1 2026), and $16.4 million (Q4 2025), per Business Quant data.